![Samir Gharib](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Samir Gharib
Financieel Directeur/CFO bij
SPRUCE BIOSCIENCES, INC.
Vermogen: 423 644 $ op 31-05-2026
Profiel
Samir M.
Gharib is currently the Director at Cancer CAREpoint since 2017.
Mr. Gharib is also the President & Chief Financial Officer at Spruce Biosciences, Inc. since 2022.
Formerly, Mr. Gharib was Finance Director & Controller at Talon Therapeutics, Inc. from 2012 to 2013.
Mr. Gharib was Managing Director at Benchmark Financial Partners LLC from 2017 to 2018.
Mr. Gharib was Vice President-Finance & Administration at Revance Therapeutics, Inc. from 2013 to 2017.
Mr. Gharib was Chief Financial Officer at Stemedica Cell Technologies, Inc. from 2018 to 2019.
Education includes an undergraduate degree conferred in 2005 and an MBA from Haas School of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 24-03-2026 | 8.263 ( 0,77% ) | 423 644 $ | 31-05-2026 |
Actieve functies van Samir Gharib
| Bedrijven | Functie | Begin |
|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Financieel Directeur/CFO | 01-05-2020 |
Cancer CAREpoint
 Cancer CAREpoint Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for treatment of cancer | Directeur/Bestuurslid | 01-11-2017 |
Eerdere bekende functies van Samir Gharib
| Bedrijven | Functie | Einde |
|---|---|---|
Stemedica Cell Technologies, Inc.
 Stemedica Cell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures adult stem cells | Financieel Directeur/CFO | 01-09-2019 |
Benchmark Financial Partners LLC | Corporate Officer/Principal | 01-10-2018 |
| REVANCE THERAPEUTICS, INC. | Financieel Directeur/CFO | 01-09-2017 |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Financieel Directeur/CFO | 01-09-2013 |
Opleiding van Samir Gharib
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
81
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Revance Therapeutics, Inc.
 Revance Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for esthetics, skincare and therapeutics | Health Technology |
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Stemedica Cell Technologies, Inc.
Stemedica Cell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures adult stem cells | Health Technology |
Haas School of Business
 Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spruce Biosciences, Inc.
 Spruce Biosciences, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company which develops novel therapies for endocrine diseases | Health Technology |
Cancer CAREpoint
Cancer CAREpoint Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for treatment of cancer | Commercial Services |
Benchmark Financial Partners LLC |
